Christina Reding

Pharmacokinetics and safety of maraviroc in neonates.

E. Acosta, L. Mcfadyen, M. Vourvahis, 2020, AIDS.

Pharmacokinetics and Safety of Zidovudine, Lamivudine, and Lopinavir/Ritonavir in HIV-infected Children With Severe Acute Malnutrition in Sub-Saharan Africa: IMPAACT Protocol P1092

P. Musoke, F. Aweeka, J. Moye, 2021, The Pediatric infectious disease journal.

Infants Receiving Very Early ART Have High CD4 Counts in the First Year of Life.

S. Spector, M. Cotton, D. Persaud, 2022, Clinical Infectious Diseases.

Etravirine in treatment-experienced HIV-1-infected children 1 year to less than 6 years of age

H. Crauwels, B. Graham, L. Fairlie, 2021, AIDS.

Early nevirapine-based antiretroviral therapy for neonates at high risk for perinatal HIV infection: pharmacokinetics and safety data from a Phase I/II Proof of Concept Study

S. Spector, M. Cotton, D. Persaud, 2021 .

Pharmacokinetics and safety of early nevirapine-based antiretroviral therapy for neonates at high risk for perinatal HIV infection: a phase 1/2 proof of concept study.

S. Spector, D. Persaud, E. Capparelli, 2020, The lancet. HIV.

HIV-1 reservoir size after neonatal antiretroviral therapy and the potential to evaluate antiretroviral-therapy-free remission (IMPAACT P1115): a phase 1/2 proof-of-concept study.

A. Kekitiinwa, M. Mirochnick, A. Coletti, 2023, The lancet. HIV.